MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Lewy bodies"

  • 2024 International Congress

    Ultrasensitive detection of aggregated α-synuclein using quiescent seed amplification assay for the diagnosis of Parkinson’s Disease

    H. Mao, Y. Kuang, P. Xu (guangzhou, China)

    Objective: To develop a technology capable of ultra-sensitive, in situ amplification of abnormal conformations of αSyn within biological samples, potentially enhancing diagnostic accuracy and shedding…
  • 2024 International Congress

    Parkinson’s Disease Risk Genotypes at the GPNMB Locus Associate with Extent of Post-mortem Lewy Pathology

    E. Brody, E. Suh, V. van Deerlin, J. Trojanowski, E. Lee, A. Chen-Plotkin (PHILADELPHIA, USA)

    Objective: To determine whether Parkinson’s disease (PD) risk genotypes at the GPNMB locus associate with distribution of Lewy pathology in brain samples from a spectrum…
  • 2024 International Congress

    Genetic determinants of the progression of Lewy body pathology

    L. Wu, AL. Gil, T. Georgiades, E. Stafford, K. Levine, M. Tan, A. Martinez Carrasco, D. Gveric, N. Wood, C. Smith, A. King, S. Love, A. Robinson, L. Parkinnen, C. Morris, J. Tunold, M. Nalls, C. Blauwendraat, A. Singleton, G. Halliday, C. Shepherd, S. Gentleman, T. Warner, Z. Jaunmuktane, L. Pihlstrom, J. Hardy, T. Lashley, R. Real, H. Morris (London, United Kingdom)

    Objective: To identify genetic risk factors associated with the distribution of Lewy body (LB) and Alzheimer’s disease (AD) co-pathology in the Lewy body disease (LBD)…
  • 2024 International Congress

    Sex Differences for Regional Lewy Body Pathology in Pathologically-Defined Lewy Body Dementia

    E. Bayram, D. Coughlin, S. Koga, I. Litvan, D. Dickson (La Jolla, USA)

    Objective: To investigate sex differences for regional Lewy body (LB) pathology burden, and regional LB pathology association with clinical diagnosis across people with a high…
  • 2024 International Congress

    Cardiovascular Associations of Cortical Lewy Bodies in the Oldest Old: The 90+ study

    R. Rajmohan, Z. Al-Darsani, N. Phielipp, T. Montine, M. Corrada, C. Kawas (Orange, USA)

    Objective: To identify potential risk factors for cortical Lewy Bodies (CLB) in the oldest-old (> 90 years old), we investigated if cardiovascular medical histories, medication…
  • 2024 International Congress

    Assessing the Accuracy of Clinical Diagnostic Criteria of Lewy Body Dementia for Detection of Lewy Body Disease in the Oldest-Old: The 90+ Study

    R. Rajmohan, Z. Al-Darsani, N. Phielipp, T. Montine, M. Corrada, C. Kawas (Orange, USA)

    Objective: To examine if Lewy Body dementia (LBD) clinical diagnostic criteria will be less accurate for detecting Lewy Body Disease (the pathological diagnosis) in the oldest-old…
  • 2023 International Congress

    Health status of Lewy Body Dementia caregivers predicts psychological response to peer mentoring intervention

    M. Suresh, K. Woo, J. Fleisher (Chicago, USA)

    Objective: To understand how caregiver health status influences response to a peer mentoring intervention in caregivers of individuals with Lewy Body Dementia (LBD). Background: Caregiving…
  • 2023 International Congress

    Sex differences for clinicopathological correlations in people with Lewy body pathology

    E. Bayram, D. Coughlin, I. Litvan (La Jolla, USA)

    Objective: To determine sex-specific clinical correlations of different Lewy body (LB), Alzheimer’s disease (AD) pathology staging and nigral neuron loss levels in people with LB…
  • 2023 International Congress

    Impact of the severity of Parkinson’s disease on skin elasticity

    SY. You, HJ. Park (Daegu, Republic of Korea)

    Objective: To investigate changes in skin elasticity according to the severity of symptoms of Parkinson's disease. Background: Parkinson's disease (PD) is a neurodegenerative disease caused…
  • 2023 International Congress

    Recruiting people at risk of Parkinson’s disease: comparative data from PPMI Online and HeBA Kassel

    E. Brown, S. Schade, S. Ghosh, K. Rege, V. Satagopam, M. Marti, W. Poewe, R. Kruger, C. Trenkwalder, L. Chahine, R. Dobkin, D. Weintraub, E. Tolosa, C. Marras, E. Bryan, J. Valverde Twiggs, M. Korell, K. Marek, B. Mollenhauer, C. Tanner (San Francisco, USA)

    Objective: To compare a US- and Germany-based staged screening process to identify people at risk of developing Parkinson’s disease (PD). Background: The Parkinson’s Progression Marker…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 10
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley